BlackRock Health Sciences Trust (NYSE:BME) Short Interest Down 30.1% in September

BlackRock Health Sciences Trust (NYSE:BME) was the recipient of a significant decrease in short interest in September. As of September 30th, there was short interest totaling 12,800 shares, a decrease of 30.1% from the September 15th total of 18,300 shares. Based on an average daily volume of 54,900 shares, the short-interest ratio is currently 0.2 days. Based on an average daily volume of 54,900 shares, the short-interest ratio is currently 0.2 days.

BlackRock Health Sciences Trust Stock Up 0.4%

Shares of NYSE:BME opened at $38.30 on Friday. BlackRock Health Sciences Trust has a 52 week low of $34.18 and a 52 week high of $41.36. The company has a 50 day moving average price of $37.09 and a two-hundred day moving average price of $36.45.

BlackRock Health Sciences Trust Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Friday, October 31st. Investors of record on Wednesday, October 15th will be given a $0.2621 dividend. The ex-dividend date is Wednesday, October 15th. This represents a c) dividend on an annualized basis and a dividend yield of 8.2%.

Institutional Trading of BlackRock Health Sciences Trust

A number of large investors have recently made changes to their positions in BME. Legacy Wealth Managment LLC ID bought a new stake in shares of BlackRock Health Sciences Trust in the 2nd quarter valued at $55,000. Farther Finance Advisors LLC bought a new stake in shares of BlackRock Health Sciences Trust in the 2nd quarter valued at $75,000. Elequin Capital LP bought a new stake in shares of BlackRock Health Sciences Trust in the 1st quarter valued at $87,000. SOA Wealth Advisors LLC. increased its position in shares of BlackRock Health Sciences Trust by 20.3% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 2,780 shares of the company’s stock valued at $103,000 after buying an additional 469 shares in the last quarter. Finally, Geneos Wealth Management Inc. increased its position in shares of BlackRock Health Sciences Trust by 200.0% in the 2nd quarter. Geneos Wealth Management Inc. now owns 4,899 shares of the company’s stock valued at $179,000 after buying an additional 3,266 shares in the last quarter.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.